Join
Live feed
·
PRReleasevia Quantisnow
Bellicum Pharmaceuticals Inc. logo

Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers Symposium

ByQuantisnow·Wall Street's wire, on your screen.
BLCM· Bellicum Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLCM (Bellicum Pharmaceuticals Inc.) and more on Quantisnow.